BioCentury | Apr 15, 2013
Company News

Helix, PharmaDerm Laboratories Ltd. deal

...The companies will develop PharmaDerm's lead products using PharmaDerm's Dermal Drug Delivery System, which provides topical...
...to purchase up to 49 percent of PharmaDerm's common stock. Upon achieving certain development milestones, PharmaDerm...
...injected but for which transdermal delivery would be preferable. Helix BioPharma Corp. (TSE:HPB), Richmond, B.C. PharmaDerm...
BioCentury | Oct 17, 2011
Clinical News

Actikerall fluorouracil/salicylic acid regulatory update

...positive recommendations for Actikerall for the indication (see BioCentury, May 16 & June 13). The PharmaDerm...
BioCentury | Jul 18, 2011
Company News

Nycomed sales and marketing update

...The PharmaDerm division of Nycomed's Nycomed U.S. Inc. subsidiary launched a program in the U.S. to...
BioCentury | Jan 3, 2005
Clinical News

Clindamax clindamycin phosphate regulatory update

...2% clindamycin phosphate vaginal cream for 3 or 7 day treatment of bacterial vaginosis (BV). PharmaDerm...
BioCentury | Nov 8, 1999
Company News

Helix, PharmaDerm Laboratories Ltd. deal

...percent of PharmaDerm it did not already own for 500,000 shares of HBP common stock. PharmaDerm...
...develops methods for injectionless delivery of large therapeutic molecules. Helix BioPHarma Corp. (TSE:HBP), Aurora, Ontario PharmaDerm...
Items per page:
1 - 5 of 5
BioCentury | Apr 15, 2013
Company News

Helix, PharmaDerm Laboratories Ltd. deal

...The companies will develop PharmaDerm's lead products using PharmaDerm's Dermal Drug Delivery System, which provides topical...
...to purchase up to 49 percent of PharmaDerm's common stock. Upon achieving certain development milestones, PharmaDerm...
...injected but for which transdermal delivery would be preferable. Helix BioPharma Corp. (TSE:HPB), Richmond, B.C. PharmaDerm...
BioCentury | Oct 17, 2011
Clinical News

Actikerall fluorouracil/salicylic acid regulatory update

...positive recommendations for Actikerall for the indication (see BioCentury, May 16 & June 13). The PharmaDerm...
BioCentury | Jul 18, 2011
Company News

Nycomed sales and marketing update

...The PharmaDerm division of Nycomed's Nycomed U.S. Inc. subsidiary launched a program in the U.S. to...
BioCentury | Jan 3, 2005
Clinical News

Clindamax clindamycin phosphate regulatory update

...2% clindamycin phosphate vaginal cream for 3 or 7 day treatment of bacterial vaginosis (BV). PharmaDerm...
BioCentury | Nov 8, 1999
Company News

Helix, PharmaDerm Laboratories Ltd. deal

...percent of PharmaDerm it did not already own for 500,000 shares of HBP common stock. PharmaDerm...
...develops methods for injectionless delivery of large therapeutic molecules. Helix BioPHarma Corp. (TSE:HBP), Aurora, Ontario PharmaDerm...
Items per page:
1 - 5 of 5